Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "C09DX03" (50)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide (C09DX03) 50 products
WHO-DDD
DrugBank.ca
L
IP
CI
Sevikar HCT 20 mg/5
mg/12.5 mg
28 Tablet(s)
17.51
35.40
10 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 20 mg/5
mg/12.5 mg
98 Tablet(s)
50.01
70.55
10 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/5
mg/12.5 mg
28 Tablet(s)
21.66
39.90
10 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/5
mg/12.5 mg
98 Tablet(s)
62.32
83.85
10 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/10
mg/12.5 mg
28 Tablet(s)
22.58
40.90
10 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/10
mg/12.5 mg
98 Tablet(s)
68.39
90.45
10 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/5 mg/25 mg
28 Tablet(s)
21.66
39.90
10 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/5 mg/25 mg
98 Tablet(s)
62.32
83.85
10 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/10
mg/25 mg
28 Tablet(s)
22.58
40.90
10 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/10
mg/25 mg
98 Tablet(s)
68.39
90.45
10 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Vascord HCT 20/5/12.5mg
28 Tablet(s)
17.51
35.40
10 %
Coated tablets: 3 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord HCT 20/5/12.5mg
98 Tablet(s)
50.01
70.55
10 %
Coated tablets: 3 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord HCT 40/5/12.5mg
28 Tablet(s)
21.66
39.90
10 %
Coated tablets: 3 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord HCT 40/5/12.5mg
98 Tablet(s)
62.32
83.85
10 %
Coated tablets: 3 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord HCT 40/10/12.5mg
28 Tablet(s)
22.58
40.90
10 %
Coated tablets: 3 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord HCT 40/10/12.5mg
98 Tablet(s)
68.39
90.45
10 %
Coated tablets: 3 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord HCT 40/5/25mg
28 Tablet(s)
21.66
39.90
10 %
Coated tablets: 3 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord HCT 40/5/25mg
98 Tablet(s)
62.32
83.85
10 %
Coated tablets: 3 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord HCT 40/10/25mg
28 Tablet(s)
22.58
40.90
10 %
Coated tablets: 3 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord HCT 40/10/25mg
98 Tablet(s)
68.39
90.45
10 %
Coated tablets: 3 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Co-Olmesartan Amlo Spirig HC 20
mg/5 mg/12.5 mg
30
17.06
34.90
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Co-Olmesartan Amlo Spirig HC 20
mg/5 mg/12.5 mg
100
46.40
66.85
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Olmesartan Amlo Spirig HC 40
mg/5 mg/12.5 mg
30
21.09
39.30
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Olmesartan Amlo Spirig HC 40
mg/5 mg/12.5 mg
100
57.82
79.25
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Olmesartan Amlo Spirig HC 40
mg/10 mg/12.5 mg
30
21.99
40.25
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Olmesartan Amlo Spirig HC 40
mg/10 mg/12.5 mg
100
63.45
85.35
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Olmesartan Amlo Spirig HC 40
mg/5 mg/25 mg
30
21.09
39.30
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Olmesartan Amlo Spirig HC 40
mg/5 mg/25 mg
100
57.82
79.25
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Olmesartan Amlo Spirig HC 40
mg/10 mg/25 mg
30
21.99
40.25
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Olmesartan Amlo Spirig HC 40
mg/10 mg/25 mg
100
63.45
85.35
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Olmesartan Amlodipin HCT
Zentiva 20 mg/5 mg/12.5 mg
28
15.93
33.75
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Olmesartan Amlodipin HCT
Zentiva 20 mg/5 mg/12.5 mg
98
45.47
65.90
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/5 mg/12.5 mg
28
19.69
37.85
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/5 mg/12.5 mg
98
56.67
78.05
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/10 mg/12.5 mg
28
20.53
38.75
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/10 mg/12.5 mg
98
62.18
84.05
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/5 mg/25 mg
28
19.69
37.85
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/5 mg/25 mg
98
56.67
78.05
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/10 mg/25 mg
28
20.53
38.75
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/10 mg/25 mg
98
62.18
84.05
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Olmesartan-Amlodipin-HCT-
Mepha 20 mg/5 mg/12,5 mg
28
15.93
33.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Olmesartan-Amlodipin-HCT-
Mepha 20 mg/5 mg/12,5 mg
98
45.47
65.90
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/5 mg/12,5 mg
28
19.69
37.85
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/5 mg/12,5 mg
98
56.67
78.05
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/10 mg/12,5 mg
28
20.53
38.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/10 mg/12,5 mg
98
62.18
84.05
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/5 mg/25 mg
28
19.69
37.85
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/5 mg/25 mg
98
56.67
78.05
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/10 mg/25 mg
28
20.53
38.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/10 mg/25 mg
98
62.18
84.05
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home